Assessing The Potential Wound Healing Abilities Of Ciclopirox
Timely and satisfactory management of any fungal or bacterial infection in the high-risk patient is the key to preventing the development of more complex, difficult-to-treat conditions that can lead to chronic, non-healing wounds, lower-extremity amputations or even death. Given its antifungal, antibacterial and antiinflammatory properties, ciclopirox has an established record of efficacy in the treatment of infections caused by dermatophytes and yeasts.
The additional discovery of the potential wound healing properties of ciclopirox by Linden, et al., strengthens the rationale for using ciclopirox not only to treat lower-extremity infections, but to help prevent the unfortunate cascade of events one often sees among high-risk patients with lower extremity ulcers.
Dr. Dockery (shown here) is a Fellow of the American Society of Podiatric Dermatology and the American College of Foot and Ankle Surgeons. He is the Founder and Director of Scientific Affairs of the Northwest Podiatric Foundation Education and Research, USA in Seattle.